2018
Vasomotor symptom characteristics
Gray KE, Katon JG, LeBlanc ES, Woods NF, Bastian LA, Reiber GE, Weitlauf JC, Nelson KM, LaCroix AZ. Vasomotor symptom characteristics. Menopause The Journal Of The North American Menopause Society 2018, 25: 520-530. PMID: 29206771, PMCID: PMC5898980, DOI: 10.1097/gme.0000000000001033.Peer-Reviewed Original ResearchConceptsVasomotor symptomsDiabetes riskNight sweatsHazard ratioHot flashesWomen's Health Initiative participantsElevated diabetes riskConfidence intervalsProportional hazards modelIncident diabetesMetabolic riskPostmenopausal symptomsMenopause transitionMean durationSymptom characteristicsInitiative participantsSymptomsDiabetesRiskBehavior changeSeverityWomenDurationSweatAssociationUnderstanding women veterans' preferences for peer support interventions to promote heart healthy behaviors: A qualitative study
Goldstein KM, Zullig LL, Oddone EZ, Andrews SM, Grewe ME, Danus S, Heisler M, Bastian LA, Voils CI. Understanding women veterans' preferences for peer support interventions to promote heart healthy behaviors: A qualitative study. Preventive Medicine Reports 2018, 10: 353-358. PMID: 29868391, PMCID: PMC5984244, DOI: 10.1016/j.pmedr.2018.04.016.Peer-Reviewed Original ResearchHeart-healthy behaviorsPeer support interventionCardiovascular diseaseWomen veteransSupport interventionsHealthy behaviorsRisk of CVDNon-insulin dependent diabetesVeterans Affairs Healthcare SystemPeer supportHealthcare systemVA healthcare systemCurrent smokingDependent diabetesPreventable conditionBehavior change goalsConventional content analysisSemi-structured individual interviewsVeterans' preferencesVeteransInterventionQualitative studyRiskIndividual interviewsHypertension
2016
Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort
Callegari LS, Gray KE, Zephyrin LC, Harrington LB, Gerber MR, Cochrane BB, Weitlauf JC, Bean-Mayberry B, Bastian LA, Mattocks KM, Haskell SG, Katon JG. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort. The Gerontologist 2016, 56: s67-s77. PMID: 26768393, PMCID: PMC5881615, DOI: 10.1093/geront/gnv666.Peer-Reviewed Original ResearchConceptsPrevalence of hysterectomyEarly hysterectomyWomen veteransBirth cohortUnadjusted prevalenceWomen's Health Initiative clinical trialsBilateral salpingo-oophorectomyLogistic regression modelsPostmenopausal veteransSalpingo-oophorectomyMultinomial logistic regression modelsClinical trialsHigh prevalenceObservational studyHysterectomyHigher oddsElevated riskClinical practiceHealth needsCohortPrevalenceBaseline dataVeteransHealth risksRisk
2015
The Association of Smoking and Acute Pancreatitis
Majumder S, Gierisch JM, Bastian LA. The Association of Smoking and Acute Pancreatitis. Pancreas 2015, 44: 540-546. PMID: 25872130, DOI: 10.1097/mpa.0000000000000301.Peer-Reviewed Original ResearchConceptsAcute pancreatitisRecurrent APCurrent smokersFormer smokersHazard ratioCigarette smokingRisk factorsSystematic reviewIndependent risk factorPooled hazard ratioAssociation of smokingRecurrent acute pancreatitisConfidence intervalsInvestigator reviewChronic pancreatitisSmoking statusCochrane DatabaseDatabase inceptionHigh riskSmokersDiscordant decisionsEligibility criteriaPancreatitisSmokingRisk
2014
Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans
Shofer S, Beyea M, Li S, Bastian LA, Wahidi MM, Kelley M, Lipkus IM. Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans. BMJ Open Respiratory Research 2014, 1: e000032. PMID: 25478181, PMCID: PMC4212704, DOI: 10.1136/bmjresp-2014-000032.Peer-Reviewed Original ResearchLung cancer riskLung cancerSmoking cessationCancer riskMethylated p16Time of enrollmentAcceptance of testingCent of participantsAirway obstructionActive smokersCurrent smokersCessation assistanceTobacco exposureCessation ratesUS veteransEpigenetic markersSmokersMethylation of p16P16 methylationCancerP16SmokingEducational materialsRiskEducational presentations
2009
Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study
Sanderson SC, O'Neill SC, White DB, Bepler G, Bastian L, Lipkus IM, McBride CM. Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study. Cancer Epidemiology Biomarkers & Prevention 2009, 18: 1953-1961. PMID: 19567511, PMCID: PMC3417294, DOI: 10.1158/1055-9965.epi-08-0620.Peer-Reviewed Original ResearchConceptsSmoking cessation servicesLung cancer riskGenetic test resultsCessation servicesCancer riskLung cancerEffective smoking cessation servicesLower lung cancer riskPersonal genetic test resultsSignificant between-group differencesBetween-group differencesGenetic risk informationClinic settingSmokersSmokers' responsesCeiling effectsPilot studyGSTM1PatientsRiskCancerCessation-related cognitionsReal-time assessmentRisk informationFurther research
2006
Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia
Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA. Vascular Risk Factors for Incident Alzheimer Disease and Vascular Dementia. Alzheimer Disease & Associated Disorders 2006, 20: 93-100. PMID: 16772744, DOI: 10.1097/01.wad.0000213814.43047.86.Peer-Reviewed Original ResearchConceptsRisk of VaDVascular risk factorsAlzheimer's diseaseRisk factorsVascular dementiaVascular factorsRisk of ADCardiovascular risk factorsCommunity-based cohortIncident Alzheimer's diseaseSelf-reported historySex differencesCardiovascular historyDementia riskDementia subtypesDiscrete-time survival modelsHigh cholesterolSubsequent riskCounty residentsVADSpecific causal pathwaysStandard criteriaHypertensionSexRisk
2005
Patients’ interest in discussing cancer risk and risk management with primary care physicians
Buchanan AH, Skinner CS, Rawl SM, Moser BK, Champion VL, Scott LL, Strigo TS, Bastian L. Patients’ interest in discussing cancer risk and risk management with primary care physicians. Patient Education And Counseling 2005, 57: 77-87. PMID: 15797155, DOI: 10.1016/j.pec.2004.04.003.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCommunicationEducational StatusFemaleGenetic CounselingHealth Care SurveysHealth Knowledge, Attitudes, PracticeHealth Services Needs and DemandHumansLogistic ModelsMaleMass ScreeningMiddle AgedNeoplasmsNorth CarolinaPatient Acceptance of Health CarePatient Education as TopicPhysician-Patient RelationsPhysicians, FamilyPrimary PreventionRisk AssessmentRisk ManagementSurveys and QuestionnairesConceptsPrimary care physiciansCancer riskCancer genetic counselingCare physiciansCancer screening modalitiesGenetic counselingColon cancer screeningColon cancer riskEducation levelPhysician visitsCancer screeningPatient preferencesScreening modalityHigher education levelPatient interestTelephone surveyPhysiciansTamoxifenRiskMore participantsGreater proportionCounselingParticipantsHealthPatients
2001
Women's Interest in Chemoprevention for Breast Cancer
Bastian L, Lipkus I, Kuchibhatla M, Weng H, Halabi S, Ryan P, Skinner C, Rimer B. Women's Interest in Chemoprevention for Breast Cancer. JAMA Internal Medicine 2001, 161: 1639-1644. PMID: 11434796, DOI: 10.1001/archinte.161.13.1639.Peer-Reviewed Original ResearchConceptsBreast cancer riskBreast cancerCancer riskGail scoreObjective breast cancer riskMammography decision aidObjective risk factorsDevelopment of cancerAbsolute riskRisk factorsChemopreventive agentsChemopreventionCancerComparative riskTelephone interviewsTamoxifen citrateDrugsWomenRiskNatural agentsCommunity sampleDecision aidScoresTherapyAgents
1998
Differences in Providers' Beliefs about Benefits and Risks of Hormone Replacement Therapy in Managed Care
Exline J, Siegler I, Bastian L. Differences in Providers' Beliefs about Benefits and Risks of Hormone Replacement Therapy in Managed Care. Journal Of Women's Health 1998, 7: 879-884. PMID: 9785314, DOI: 10.1089/jwh.1998.7.879.Peer-Reviewed Original ResearchConceptsHormone replacement therapyRisks of HRTReplacement therapyBreast cancerFamily physiciansBenefits of HRTProviders' beliefsProvider-patient discussionsGender of physiciansHealth maintenance organizationCross-sectional surveyThromboembolic eventsHeart diseasePhysicians' beliefsPhysician genderCare settingsFemale providersAlzheimer's diseasePhysician assistantsFemale physiciansMaintenance organizationPhysiciansDiseaseManaged CareRiskPromoting Informed Decision Making: Hormone Replacement Therapy
Bastian L, Couchman G, Rimer B, McBride C, Sutton L, Siegler I. Promoting Informed Decision Making: Hormone Replacement Therapy. Cancer Treatment And Research 1998, 97: 129-147. PMID: 9711414, DOI: 10.1007/978-0-585-30498-4_10.Peer-Reviewed Original ResearchConceptsHormonal replacement therapyReplacement therapyBreast cancerHormone replacement therapyRisk of cancerHRT useMenopausal symptomsMost gynecologistsHeart diseaseHigh riskNumber of womenAverage life expectancyCancerCancer issuesLife expectancyWomenMenopausePatientsTherapyRiskOsteoporosisGynecologistsSymptomsDiseasePhysicians